Boai NKY Medical Holdings Ltd. (300109.SZ)
CNY 14.85
(0.13%)
CNY 14.85
(0.13%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 493.02 Million CNY | 69.16% |
| 2022 | 291.46 Million CNY | -0.56% |
| 2021 | 293.11 Million CNY | 797.95% |
| 2020 | 32.64 Million CNY | -73.42% |
| 2019 | 122.79 Million CNY | 37.13% |
| 2018 | 89.54 Million CNY | -3.53% |
| 2017 | 92.82 Million CNY | 15.97% |
| 2016 | 80.03 Million CNY | 40.46% |
| 2015 | 56.98 Million CNY | 89.21% |
| 2014 | 30.11 Million CNY | 49.36% |
| 2013 | 20.16 Million CNY | 0.46% |
| 2012 | 20.07 Million CNY | -19.45% |
| 2011 | 24.92 Million CNY | 8.23% |
| 2010 | 23.02 Million CNY | 26.46% |
| 2009 | 18.2 Million CNY | 75.95% |
| 2008 | 10.34 Million CNY | 65.27% |
| 2007 | 6.26 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 98.31 Million CNY | 7.4% |
| 2024 Q2 | 91.54 Million CNY | -24.59% |
| 2024 Q1 | 121.38 Million CNY | 37.77% |
| 2023 Q2 | 142.22 Million CNY | 18.54% |
| 2023 Q3 | 142.71 Million CNY | 0.34% |
| 2023 Q4 | 88.1 Million CNY | -38.26% |
| 2023 FY | 493.02 Million CNY | 69.16% |
| 2023 Q1 | 119.97 Million CNY | 1577.82% |
| 2022 Q3 | 131.43 Million CNY | 15.8% |
| 2022 FY | 291.46 Million CNY | -0.56% |
| 2022 Q4 | 7.15 Million CNY | -94.56% |
| 2022 Q2 | 113.5 Million CNY | 248.12% |
| 2022 Q1 | 32.6 Million CNY | -83.11% |
| 2021 FY | 293.11 Million CNY | 797.95% |
| 2021 Q3 | 16.6 Million CNY | -21.04% |
| 2021 Q1 | 62.43 Million CNY | 293.49% |
| 2021 Q2 | 21.03 Million CNY | -66.32% |
| 2021 Q4 | 193.04 Million CNY | 1062.49% |
| 2020 Q4 | -32.26 Million CNY | -223.0% |
| 2020 FY | 32.64 Million CNY | -73.42% |
| 2020 Q3 | 26.23 Million CNY | -32.04% |
| 2020 Q2 | 38.6 Million CNY | 221.5% |
| 2020 Q1 | 12 Million CNY | -35.84% |
| 2019 Q4 | 18.71 Million CNY | -57.37% |
| 2019 FY | 122.79 Million CNY | 37.13% |
| 2019 Q1 | 28.98 Million CNY | 209.73% |
| 2019 Q2 | 31.2 Million CNY | 7.64% |
| 2019 Q3 | 43.89 Million CNY | 40.68% |
| 2018 Q2 | 29.17 Million CNY | 19.94% |
| 2018 Q1 | 24.32 Million CNY | 38.58% |
| 2018 FY | 89.54 Million CNY | -3.53% |
| 2018 Q4 | 9.35 Million CNY | -64.93% |
| 2018 Q3 | 26.68 Million CNY | -8.54% |
| 2017 FY | 92.82 Million CNY | 15.97% |
| 2017 Q4 | 17.55 Million CNY | -26.92% |
| 2017 Q3 | 24.01 Million CNY | -11.52% |
| 2017 Q2 | 27.14 Million CNY | 12.63% |
| 2017 Q1 | 24.1 Million CNY | 50.38% |
| 2016 Q4 | 16.02 Million CNY | -25.01% |
| 2016 FY | 80.03 Million CNY | 40.46% |
| 2016 Q1 | 20.46 Million CNY | 15.93% |
| 2016 Q2 | 22.17 Million CNY | 8.36% |
| 2016 Q3 | 21.37 Million CNY | -3.61% |
| 2015 Q3 | 13.46 Million CNY | 4.91% |
| 2015 FY | 56.98 Million CNY | 89.21% |
| 2015 Q1 | 13.03 Million CNY | 93.85% |
| 2015 Q2 | 12.83 Million CNY | -1.58% |
| 2015 Q4 | 17.65 Million CNY | 31.12% |
| 2014 Q1 | 5.49 Million CNY | 43.45% |
| 2014 FY | 30.11 Million CNY | 49.36% |
| 2014 Q4 | 6.72 Million CNY | -28.07% |
| 2014 Q3 | 9.35 Million CNY | 9.4% |
| 2014 Q2 | 8.54 Million CNY | 55.59% |
| 2013 Q4 | 3.82 Million CNY | -23.24% |
| 2013 Q2 | 6.42 Million CNY | 30.85% |
| 2013 Q3 | 4.98 Million CNY | -22.34% |
| 2013 Q1 | 4.9 Million CNY | 26.35% |
| 2013 FY | 20.16 Million CNY | 0.46% |
| 2012 Q4 | 3.88 Million CNY | -13.02% |
| 2012 Q1 | 5.54 Million CNY | 16.4% |
| 2012 FY | 20.07 Million CNY | -19.45% |
| 2012 Q2 | 6.17 Million CNY | 11.41% |
| 2012 Q3 | 4.46 Million CNY | -27.68% |
| 2011 Q1 | 5.26 Million CNY | 3.06% |
| 2011 Q3 | 5.88 Million CNY | -32.89% |
| 2011 FY | 24.92 Million CNY | 8.23% |
| 2011 Q4 | 4.76 Million CNY | -19.1% |
| 2011 Q2 | 8.77 Million CNY | 66.64% |
| 2010 Q1 | 5.91 Million CNY | 22.52% |
| 2010 Q2 | 6.27 Million CNY | 6.11% |
| 2010 FY | 23.02 Million CNY | 26.46% |
| 2010 Q4 | 5.1 Million CNY | -10.88% |
| 2010 Q3 | 5.73 Million CNY | -8.64% |
| 2009 Q3 | 5.54 Million CNY | 0.0% |
| 2009 Q4 | 4.82 Million CNY | -12.97% |
| 2009 FY | 18.2 Million CNY | 75.95% |
| 2008 FY | 10.34 Million CNY | 65.27% |
| 2007 FY | 6.26 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 488.73 Million CNY | -0.879% |
| Zhejiang Zhenyuan Share Co., Ltd. | 81.64 Million CNY | -503.885% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | -215.14 Million CNY | 329.161% |
| Hubei Guangji Pharmaceutical Co., Ltd. | -140.24 Million CNY | 451.539% |
| Yifan Pharmaceutical Co., Ltd. | -551.07 Million CNY | 189.467% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 34.32 Million CNY | -1336.55% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 2.45 Billion CNY | 79.927% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | -8.92 Million CNY | 5622.675% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 310.18 Million CNY | -58.946% |